Streetbeat News

Analyst Ratings

GTHX

G1 Therapeutics' stock price is trading lower following adjustments in price targets by Needham and Wedbush. Needham maintained a Buy rating but reduced its price target from $14 to $12. Similarly, Wedbush kept its Outperform rating but lowered its price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:48 pm

WCC

RBC Capital analyst Deane Dray downgraded WESCO Intl (WCC) from Outperform to Sector Perform and reduced the price target from $202 to $173.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:43 pm

LCTX

HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Lineage Cell Therapeutics (LCTX) and maintained a $7 price target. This reaffirms the firm's positive outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:38 pm

CALC

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on CalciMedica (NASDAQ:CALC) and maintained a $20 price target. This reaffirms the firm's positive outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:37 pm

STTK

HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Shattuck Labs (NASDAQ:STTK) and maintained a $28 price target.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:33 pm

PBYI

HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Puma Biotechnology (NASDAQ:PBYI) and maintained an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:29 pm

ANIX

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Anixa Biosciences (NASDAQ:ANIX) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:28 pm

AMD

AVGO

CRDO

INTC

NVDA

SOXX

Mizuho Securities has increased its price targets for Nvidia, AMD, Broadcom, and Credo Technology, citing the booming AI market expected to reach $400 billion by 2027. Nvidia, AMD, Broadcom, and Intel are projected to be major beneficiaries of this growth, with significant increases in their AI revenue forecasts. The analyst highlights strong demand for AI chips, tight supplies of Nvidia's H100 AI accelerator chipset, and anticipates further acceleration in demand in 2024. Nvidia's upcoming B100 launch is also seen positively for its 2024 guidance.

Portfolio Pulse from Shanthi Rexaline

February 13, 2024 | 5:25 pm

TRU

Needham analyst Kyle Peterson has maintained a Buy rating on TransUnion (NYSE:TRU) and increased the price target from $75 to $87.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:18 pm

DDOG

Needham analyst Mike Cikos has maintained a Buy rating on Datadog (NASDAQ:DDOG) and increased the price target from $125 to $165.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:16 pm